MedPlus Health Services has debuted at Rs 1015.00 on the BSE, up by 219.00 points or 27.51% from its issue price of Rs 796.
The scrip is currently trading at Rs 1099.60, up by 303.60 points or 38.14% from its issue price. It has touched a high and low of Rs 1100.00 and Rs 1015.00 respectively. So far 4.24 lakh shares were traded on the counter.
The initial public offering of the pharmacy retailer saw strong demand as investors subscribed the IPO about 53 times during December 13, 2021 to December 15, 2021. Qualified institutional buyers' portion was booked 112 times, followed by non-institutional investors, 85 times. The issue price was fixed at Rs 796 per share i.e. at upper end of price band of Rs 780-796 apiece.
MedPlus Health Services offers a wide range of products, including pharmaceutical and wellness products such as medicines, vitamins, medical devices and test kits, and FMCG products such as home and personal care products, including toiletries, baby care products, soaps and detergents and sanitizers.
| Company Name | CMP |
|---|---|
| Avenue Supermarts | 4629.25 |
| Trent | 4105.95 |
| Vishal Mega Mart | 118.90 |
| Aditya Birla Lifesty | 105.86 |
| PN Gadgil Jewellers | 667.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: